Sfoglia per AUTORE
LIVI L
Collezione AO Cuneo

  

Items : 13

Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO. in Neuro-oncology / Neuro Oncol. 2021 Oct 1;23(10):1750-1764. doi: 10.1093/neuonc/noab129.

2021
AO Cuneo
AOU Novara

Livi L; Navarria P; Ricardi U; Scotti V; Fariselli L; Muto P; Maranzano E; Pecchioli G; Desideri I; Giaj-Levra N; Pedretti S; Krengli M; Trignani M; Merlotti A; Giudice E; Ciammella P; Bruni A; Pasqualetti F; Tini P; Mantovani C; Beltramo G; Franceschini D; Matteucci P; Anselmo P; Di Franco R; Caini S; Pinzi V; Osti MF; Olmetto E; et alii...

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial. in Scientific reports / Sci Rep. 2021 Jul 2;11(1):13770. doi: 10.1038/s41598-021-92774-z.

2021
AO Cuneo

Vici P; Ciliberto G; Sanguineti G; Di Leo A; De Maria R; Daralioti T; Sperduti I; Perracchio L; di Benedetto A; Del Medico P; Roselli M; Vaccaro A; Garufi C; Cazzaniga M; Lorusso V; Russo A; Pistelli M; Giotta F; Meattini I; Garrone O; Paris I; Sarobba G; Veltri E; Corsi D; D'Ostilio N; Grassadonia A; Valerio MR; Mirabelli R; Fabbri MA; et alii...

Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review. in Oral oncology / Oral Oncol. 2021 Aug;119:105355. doi: 10.1016/j.oraloncology.2021.105355. Epub 2021 May 24.

2021
AO Cuneo

Desideri I; Becherini C; Belgioia L; Merlotti A; Ciccone LP; Franzese C; Loi M; De Felice F; Mazzola R; Caini S; Livi L; Bonomo P;

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence. in Journal of cellular physiology / J Cell Physiol. 2020 Nov;235(11):7900-7910. doi: 10.1002/jcp.29445. Epub 2020 Jan 15.

2020
AO Cuneo

Vici P; Giordano A; Barba M; Mazzotta M; Sperduti I; Ciliberto G; Villa A; Risi E; De Maria R; Del Medico P; Generali D; Meattini I; Livi L; Garrone O; Baldini E; Zamagni C; Pistelli M; Cannita K; Valerio MR; Berardi R; Russo A; Ricciardi G; Adamo V; Ficorella C; Roselli M; Lorusso V; Landucci E; Paris I; Giotta F; et alii...

Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study. in European journal of hybrid imaging / Eur J Hybrid Imaging. 2020 May 26;4(1):8. doi: 10.1186/s41824-020-00077-9.

2020
AO Cuneo

Belli G; Scalone F; Cicchetti S; Vigo F; Roncali M; Ursino S; Volterrani D; Pirro V; Berretta L; Travaini L; Alterio D; D'Angelo E; Casolo A; Lopci E; Franzese C; Belgioia L; Bacigalupo A; Bergesio F; Saieva C; Berti V; Morbelli S; Merlotti A; Bonomo P; Cauda S; Desideri I; Russi E; Livi L; Bianchi A;

Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic. in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology / Radiother Oncol. 2020 Jun;147:229-230. doi: 10.1016/j.radonc.2020.04.034. Epub 2020 Apr 24.

2020
AO Cuneo

Buglione M; Livi L; Alongi F; Russi E; Vagge S; Arcangeli S; Corvò R; Jereczek-Fossa BA; Scorsetti M; Filippi AR; Borghetti P; Magrini SM;

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies. in Breast care (Basel, Switzerland) / Breast Care (Basel). 2020 Feb;15(1):30-37. doi: 10.1159/000495469. Epub 2019 Apr 17.

2020
AO Cuneo

Mustacchi G; Pronzato P; Torri V; Marchetti P; Montemurro F; Riccardi F; Romagnoli E; Bisagni G; Livi L; Natoli C; Donadio M; Biganzoli L; Del Mastro L; Clivio L; Giordano M; Frassoldati A; Scavelli C; Ferzi A; Schirone A; Palumbo R; Gebbia V; Fabi A; Santini D; Turletti A; Porpiglia M; Atzori F; Blasi L; De Laurentiis M; Artale S; et alii...

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2020 Dec 10;39(1):279. doi: 10.1186/s13046-020-01797-3.

2020
AO Cuneo

Roselli M; Del Medico P; Cazzaniga M; Garufi C; Sarobba G; Giotta F; Paris I; Garrone O; Veltri E; Corsi D; D'Ostilio N; Fabbri MA; Russo A; Mirabelli R; Valerio MR; Marchetti P; Tomao S; Marinelli D; Mazzotta M; Barchiesi G; Zamagni C; Tonini G; Adamo V; Michelotti A; Moscetti L; Bria E; Cassano A; La Verde N; Generali D; et alii...

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting. in International journal of cancer / Int J Cancer. 2020 Apr 1;146(7):1917-1929. doi: 10.1002/ijc.32583. Epub 2019 Aug 7.

2020
AO Cuneo

Vici P; Di Leo A; Barba M; Villa A; Ciliberto G; Sperduti I; De Maria R; Risi E; Generali D; De Tursi M; Sarobba G; Del Medico P; Meattini I; Desideri I; Livi L; Baldini E; Di Cocco B; Foglietta J; Greco F; Zamagni C; Garrone O; D'Ostilio N; Sini V; Cannita K; Adamo V; Ricciardi GRR; Fiorio E; Pistelli M; Russo A; et alii...

Current state of interventional radiotherapy (brachytherapy) education in Italy: results of the INTERACTS survey. in Journal of contemporary brachytherapy / J Contemp Brachytherapy. 2019 Feb;11(1):48-53. doi: 10.5114/jcb.2019.83137. Epub 2019 Feb 28.

2019
AO Cuneo

Ricardi U; Giovagnoni A; Corvò R; Livi L; Russi E; Pieters BR; Casà C; Morganti AG; Barbera F; De Sanctis V; Aristei C; Valentini V; Magrini SM; Kovács G; Tagliaferri L;

Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Feb;134:104-119. doi: 10.1016/j.critrevonc.2018.11.006. Epub 2018 Nov 3

2019
AO Cuneo

Trovò M; Russi E; Ricardi U; Ramella S; Pergolizzi S; Palumbo I; Merlotti A; Meattini I; Mazzola R; Marvaso G; Magrini SM; Livi L; Greco C; Fiore M; Genovesi D; Filippi AR; D'Angelillo RM; Caravatta L; Buglione M; Belgioia L; Becherini C; Aristei C; Alongi F; Jereczek-Fossa BA; Arcangeli S; Sindoni A; Valentini V; Corvò R;

Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Feb;134:87-103. doi: 10.1016/j.critrevonc.2018.11.005. Epub 2018 Dec 1.

2019
AO Cuneo

Trovò M; Russi E; Ricardi U; Ramella S; Pergolizzi S; Palumbo I; Merlotti A; Meattini I; Mazzola R; Marvaso G; Magrini SM; Livi L; Greco C; Fiore M; Genovesi D; Filippi AR; D'Angelillo RM; Caravatta L; Buglione M; Belgioia L; Becherini C; Aristei C; Alongi F; Jereczek-Fossa BA; Arcangeli S; Sindoni A; Valentini V; Corvò R;

What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2122-2138. doi: 10.1007/s00259-018-4065-5. Epub 2018 Jun

2018
AO Cuneo

Livi L; Orlandi E; Franzese C; Franco P; Bacigalupo A; Desideri I; Bianchi A; Olmetto E; Caini S; Merlotti A; Bonomo P;